C. Neef

First name

C.

Last name

Neef

Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E., Neef, C., Cooper, C., & de Vries, F. (2013). Risk of fracture in patients with Parkinson\textquoterights disease. Osteoporos Int. http://doi.org/10.1007/s00198-013-2300-2

View

Driessen, J. H., van Onzenoort, H. A., Henry, R. M., Lalmohamed, A., van den Bergh, J. P., Neef, C., et al. (2014). Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture. Bone. http://doi.org/10.1016/j.bone.2014.07.030

View

der Zanden, W., de Vries, F., Lalmohamed, A., Driessen, J. H., de Boer, A., Rohde, G., et al. (2015). Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study. PLoS One. http://doi.org/10.1371/journal.pone.0139367

View

Driessen, J. H., Henry, R. M., van Onzenoort, H. A., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., et al. (2015). Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int. http://doi.org/10.1007/s00223-015-9993-5

View

Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., et al. (2016). Use of incretin agents and risk of pancreatic cancer: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12605

View